A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis

Abstract Introduction Historically, patients with skin of color are underdiagnosed with psoriasis and underrepresented in clinical trials. In this study, we assess the efficacy and safety of risankizumab in patients with moderate-to-severe plaque psoriasis by race and ethnicity in the open label ext...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Andrew F. Alexis, Melinda Gooderham, Shawn G. Kwatra, Ahmad Amin, Susan Taylor, Ramon Espaillat, Trisha Rettig, Tianshuang Wu, Linyu Shi, Mark I. Kaldas, Deanne M. Dilley, Ranjeeta Sinvhal, Chudy Nduaka, Benjamin Lockshin
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Adis, Springer Healthcare 2024-10-01
Serie:	Dermatology and Therapy
Ämnen:	Skin of color Psoriasis Race Ethnicity Efficacy Diversity
Länkar:	https://doi.org/10.1007/s13555-024-01268-z
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!